FUSION™ is a feature-rich software application for biomarker discovery utilizing a broad range of multiscale biochemical data and advanced machine learning technologies. FUSION allows researchers to identify clinical and molecular signatures of pathogenic processes and disease progression for new drug development and companion diagnostics, to support clinical trial monitoring, and for improved post-marketing safety assessment. FUSION is a complete solution providing clinical and experimental data, biochemical knowledge, and automated model development in one integrated system. FUSION can be live linked with NGS technologies, high-complexity assays, and digital instrumentation for real-time analysis and process characterization. FUSION is accelerating biomarker discovery in support of precision medicine and next generation clinical care.
Molecular Intelligence. Precision Models. Accelerated Research.™